Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effects of EDTA on End-Point Detection Methods01:18

Effects of EDTA on End-Point Detection Methods

Different methods, such as visual observance of metal-ion indicators, spectroscopic techniques, and potentiometric methods, can determine the endpoint of an EDTA titration.
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a result, EDTA...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A systematic review and meta-analysis of the relationship between physical activity and procrastination behavior.

Acta psychologica·2026
Same author

STGBench: sequencing-level spatial DNA-RNA simulation for multimodal and virtual cell-oriented benchmarking of genomic alterations.

Briefings in bioinformatics·2026
Same author

Network analysis of anxiety and depression in college students with different levels of physical activity.

Scientific reports·2026
Same author

Genome-wide analysis of the LAR gene family and the role of OvLAR71 in proanthocyanidin biosynthesis in Onobrychis viciifolia.

Plant physiology and biochemistry : PPB·2026
Same author

Microfluidic filtration enrichment cascade nanozyme-catalyzed colorimetric immunoassay for rapid and ultrasensitive detection of <i>Escherichia coli</i> in urine with smartphone readout.

Analytical methods : advancing methods and applications·2026
Same author

A comparative study of machine learning models for microbiome-based diagnosis and multi-class staging of colorectal cancer.

Scientific reports·2026

Related Experiment Video

Updated: May 13, 2026

Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

12.2K

MRDagent: iterative and adaptive parameter optimization for stable ctDNA-based MRD detection in heterogeneous

Tianci Wang1,2, Xin Lai1,2, Shenjie Wang3

  • 1School of Computer Science and Technology, Xi'an Jiaotong University, Xi'an, Shaanxi, 710049, China.

Bioinformatics (Oxford, England)
|September 1, 2025
PubMed
Summary
This summary is machine-generated.

MRDagent enhances minimal residual disease (MRD) detection using next-generation sequencing (NGS) by employing an adaptive framework and a CNN meta-model for stable and efficient variant calling from circulating tumor DNA (ctDNA). This tool offers a reliable solution for clinical applications.

More Related Videos

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions
08:23

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions

Published on: September 25, 2018

13.4K
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

8.8K

Related Experiment Videos

Last Updated: May 13, 2026

Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

12.2K
Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions
08:23

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions

Published on: September 25, 2018

13.4K
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

8.8K

Area of Science:

  • Oncology
  • Bioinformatics
  • Genomics

Background:

  • Minimal residual disease (MRD) is a critical prognostic biomarker in cancer management, but its detection via next-generation sequencing (NGS)-based circulating tumor DNA (ctDNA) analysis is challenging due to low variant allele frequency (VAF) and sample heterogeneity.
  • Current methods struggle with stable MRD detection because of the need for individualized parameter tuning, interdependent workflow parameters, and limitations in automated optimization.

Purpose of the Study:

  • To develop a novel variant detection tool, MRDagent, specifically designed for robust and stable minimal residual disease (MRD) detection.
  • To address the challenges of parameter optimization in MRD detection workflows by creating an adaptive and efficient computational solution.

Main Methods:

  • MRDagent utilizes an iterative, self-adaptive optimization framework to manage complex and coupled parameters across different stages of variant detection.
  • Integration of a convolutional neural network (CNN)-based meta-model for rapid parameter prediction, trained on historical data to improve computational efficiency and generalizability.

Main Results:

  • MRDagent demonstrates superior and stable performance in MRD detection across simulated and real-world datasets.
  • The tool provides an efficient and reliable solution for MRD detection, enhancing the utility of ctDNA analysis in clinical and high-throughput research.

Conclusions:

  • MRDagent offers a significant advancement in MRD detection technology, overcoming key limitations of existing methods.
  • The developed tool is freely available, facilitating its adoption in clinical practice and research for improved cancer patient management.